Company patents
Cardio Flow, Inc.
Cardio Flow, Inc. exhibits a highly concentrated patent strategy, with 100% of its 50 patents in Medical Diagnostics & Surgery, which surprisingly saw a significant 30.8% growth in 2025 after a decline, though patenting so far in 2026 is down 70.6%. The company's minor interest in Drug Delivery Devices, representing only 6.0% of its portfolio, appears to be a shifting priority given its 100% year-over-year decline in 2024 and again so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
50 US filings (since 2023) · 2 categories · 2 themes
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Patents
Showing 41-50 of 140